FILE PHOTO: Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann/File Photo

Political News, Analysis and Opinion
The Real News Network
FILE PHOTO: Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann/File Photo